Hemostatic Abnormality and Associated Factors in Diabetic Patients at Jimma University Specialized Hospital, Jimma, Southwest Ethiopia: A Comparative Cross-sectional Study.
Associated factors
Diabetes Mellitus
Hemostasis
Journal
Ethiopian journal of health sciences
ISSN: 2413-7170
Titre abrégé: Ethiop J Health Sci
Pays: Ethiopia
ID NLM: 101224773
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
entrez:
24
4
2019
pubmed:
24
4
2019
medline:
11
10
2019
Statut:
ppublish
Résumé
Diabetes mellitus is a group of heterogeneous disorders of multiple etiologies characterized by chronic hyperglycemia resulting from defects in insulin secretion and/or insulin action. Diabetes mellitus has been reported to disturb normal hemostasis by various mechanisms. However, data on hemostasis of diabetic patients in the study area are lacking. This study was aimed at determining hemostatic profile and associated factors of hemostatic abnormality in diabetic patients. A comparative cross-sectional study was conducted involving a total of 238 (119 diabetic and 119 apparently healthy) individuals who came to the chronic care clinic, Jimma University Specialized Hospital. Socio-demographic and clinical data were collected through a structured questionnaire. A blood sample of 10ml was collected in EDTA (4ml), citrate (3ml) and chemistry (3ml) tubes to do platelet count, coagulation tests, and glucose and lipid profile analysis, respectively. Descriptive statistics as well as the median (25 The overall hemostatic abnormality in diabetes individuals was 58.8%. The median (25th, 75th percentile) prothrombin time for diabetic and non-diabetic subjects was (12.8, 15.6) vs. (12.8, 14.2), respectively, and the difference was not statistically significant (p>0.05). The median (25 An overall hemostatic abnormality in diabetic patients was found to be high. The APTT and platelet count were lower in diabetic patients whilst the fibrinogen level was higher. Routine coagulation tests should be part of tests among diabetic patients. Advanced coagulation tests should also be considered to identify specific markers so as to pinpoint the particular problem.
Sections du résumé
BACKGROUND
BACKGROUND
Diabetes mellitus is a group of heterogeneous disorders of multiple etiologies characterized by chronic hyperglycemia resulting from defects in insulin secretion and/or insulin action. Diabetes mellitus has been reported to disturb normal hemostasis by various mechanisms. However, data on hemostasis of diabetic patients in the study area are lacking. This study was aimed at determining hemostatic profile and associated factors of hemostatic abnormality in diabetic patients.
METHODS
METHODS
A comparative cross-sectional study was conducted involving a total of 238 (119 diabetic and 119 apparently healthy) individuals who came to the chronic care clinic, Jimma University Specialized Hospital. Socio-demographic and clinical data were collected through a structured questionnaire. A blood sample of 10ml was collected in EDTA (4ml), citrate (3ml) and chemistry (3ml) tubes to do platelet count, coagulation tests, and glucose and lipid profile analysis, respectively. Descriptive statistics as well as the median (25
RESULTS
RESULTS
The overall hemostatic abnormality in diabetes individuals was 58.8%. The median (25th, 75th percentile) prothrombin time for diabetic and non-diabetic subjects was (12.8, 15.6) vs. (12.8, 14.2), respectively, and the difference was not statistically significant (p>0.05). The median (25
CONCLUSION
CONCLUSIONS
An overall hemostatic abnormality in diabetic patients was found to be high. The APTT and platelet count were lower in diabetic patients whilst the fibrinogen level was higher. Routine coagulation tests should be part of tests among diabetic patients. Advanced coagulation tests should also be considered to identify specific markers so as to pinpoint the particular problem.
Identifiants
pubmed: 31011273
doi: 10.4314/ejhs.v29i2.12
pii: jEJHS.v29.i2.pg251
pmc: PMC6460446
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
251-258Références
J Diabetes Complications. 2001 Jan-Feb;15(1):44-54
pubmed: 11259926
J Diabetes Complications. 2004 May-Jun;18(3):173-6
pubmed: 15145330
Am J Med. 2008 Mar;121(3):231-8
pubmed: 18328308
Diabetes Care. 2009 Jan;32 Suppl 1:S62-7
pubmed: 19118289
Diab Vasc Dis Res. 2010 Oct;7(4):251-9
pubmed: 20921090
PLoS One. 2011 Jan 28;6(1):e16470
pubmed: 21297995
Int J Endocrinol. 2011;2011:742719
pubmed: 21869886
Blood Coagul Fibrinolysis. 2011 Oct;22(7):600-5
pubmed: 21934489
Blood. 2012 Jun 21;119(25):6136-44
pubmed: 22431576
Physiol Rev. 2013 Jan;93(1):327-58
pubmed: 23303912
BMC Res Notes. 2013 Nov 25;6:485
pubmed: 24274772
Ghana Med J. 2017 Sep;51(3):101-107
pubmed: 29622820
EJIFCC. 2002 Dec 01;13(5):205-209
pubmed: 30349439
Diabetologia. 1993 Nov;36(11):1119-25
pubmed: 8270125